Hoth Therapeutics Rebrands as Rocket One, Secures Exclusive Nanomagnetic AI Chip License
HOTH•Hoth Therapeutics completed its corporate name change to Rocket One Inc. effective May 26 and will trade under ticker RKTO starting May 28. The company secured an exclusive license for a next-generation nanomagnetic AI chip designed for ultra-low-power, radiation-tolerant space and defense computing.
1. Rebranding and New Ticker
Hoth Therapeutics completed its legal name change to Rocket One Inc. effective May 26, 2026, and will begin trading under Nasdaq symbol RKTO at market open on May 28. The rebranding underscores the company’s pivot to the orbital economy and space-focused computing solutions.
2. Exclusive Nanomagnetic AI Chip License
Rocket One secured exclusive worldwide rights to a next-generation nanomagnetic AI chip architecture designed for ultra-low-power, radiation-tolerant computing. The chip retains data without power during satellite power cycles, consumes dramatically less energy per calculation, and features a compact footprint ideal for small satellites and deep-space platforms.
3. Strategic Market Opportunities
The company plans to address three converging segments: orbital AI hardware, nano-launch and nanosatellite enablement, and defense and national security computing. Falling launch costs and growing demand for resilient on-orbit intelligence create a favorable environment for Rocket One’s technology platform.
4. Biotechnology Programs Remain Subsidiary
Rocket One’s legacy biotechnology pipeline, including HT-001, HT-KIT and its GDNF-based metabolic program, will continue under a wholly owned subsidiary. This structure allows the company to advance its neuroscience and metabolic treatments alongside its new space technology focus.
